Back to Search
Start Over
FDA approves Perjeta for neoadjuvant breast cancer treatment: First drug approved for use in preoperative breast cancer
- Source :
- Chemical Business Newsbase. September 30, 2013
- Publication Year :
- 2013
-
Abstract
- On 30 Sep 2013, the US Food and Drug Administration granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Chemical Business Newsbase
- Publication Type :
- News
- Accession number :
- edsgcl.347636302